Evidence map›Paper›PMID 39135632›Full record

ArticleJBMR plus2024

Differences in tissue-level properties as assessed by nano-scratching in patients with and without atypical femur fractures on long-term bisphosphonate therapy: a proof-of-concept pilot study.

Gabriel Johnson, Lanny V Griffin, Shijing Qiu, Sudhaker D Rao

Abstract read
In one paragraph

Article in JBMR plus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gabriel JohnsonDepartment of Biomedical Engineering, California Polytechnic State University (Cal Poly), San Luis Obispo, CA, 93407-0365, United States.
Lanny V GriffinDepartment of Biomedical Engineering, California Polytechnic State University (Cal Poly), San Luis Obispo, CA, 93407-0365, United States.
Shijing QiuBone & Mineral Research Laboratory, Henry Ford Health/Wayne State University Integrative Biosciences (IBio) Research Facility, Detroit, MI, 48202, United States.
Sudhaker D RaoBone & Mineral Research Laboratory, Henry Ford Health/Wayne State University Integrative Biosciences (IBio) Research Facility, Detroit, MI, 48202, United States.ORCID https://orcid.org/0000-0002-2200-1800

Funding

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate TherapyR01AR062103 · NIAMS · HENRY FORD HEALTH SYSTEM · PI RAO, D. SUDHAKER SUDHAKER · 2013 to 2016
$1.3M
NIAMS NIH HHS R01 AR062103
6 · The paper itself

Abstract

Atypical femur fractures (AFFs) are a well-established complication of long-term bisphosphonate (BP) therapy, but their pathogenesis is not fully understood. Although many patients on long-term BP therapy have severe suppression of bone turnover (SSBT), not all such patients experience AFF, even though SSBT is a major contributor to AFF. Accordingly, we evaluated tissue level properties using nano-scratch testing of trans-iliac bone biopsy specimens in 12 women (6 with and 6 without AFF matched for age and race). Nano-scratch data were analyzed using a mixed-model ANOVA with volume-normalized scratch energy as a function of AFF (Yes or No), region (periosteal or endosteal), and a first-order interaction between region and AFF. Tukey post hoc analyses of the differences of least squared means of scratch energy were performed and reported as significant if

Indexed as

alendronateatypical femur fracturecortical bonenano-scratchseverely suppressed bone turnover

Identifiers

PMID39135632
PMCPMC11318351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.